Standardized mNGS workflow improves reproducibility of gut microbiome analysis

When researchers sequence the bacteria living in your gut, they are trying to answer a straightforward question: what microbes are actually there, and in what proportions? The problem is that the answer keeps changing depending on how the sample was handled before it reached the sequencer. A swab stored in one type of buffer might show a different community composition than the same swab stored in another. A sample extracted by one technician might yield different abundance measurements than the same sample extracted by someone else. These technical inconsistencies have long plagued microbiome research, making it hard to trust whether differences between patients reflect real biology or merely reflect the choices made in the lab.

A research team set out to build a standardized workflow that would reduce this noise. They started with the most basic decision: how to preserve a sample from the moment it leaves the body until it reaches the sequencer. They tested three commercial preservation buffers, labeled A, B, and C, to see which one best maintained the original microbial community. Buffer B emerged as the winner on this measure—it kept the microbiome composition closest to what was actually present at the time of collection. But preservation is only half the problem. Samples also need to survive the journey. The researchers subjected their preserved samples to nine days of incubation at 37 degrees Celsius, simulating thermal stress that might occur during shipping or storage. Under these harsh conditions, buffer C proved most resilient. It maintained the structural integrity of the microbial community better than the other two, resisting the drift that typically occurs when samples sit at body temperature for extended periods.

The choice between these buffers, then, depends on what a researcher prioritizes. If the goal is to capture the microbiome as it existed at the moment of sampling, buffer B is the better choice. If the study involves samples that might spend days in transit or storage, buffer C offers more stability. This kind of practical guidance—acknowledging that different applications have different needs—is what makes the workflow useful rather than merely prescriptive.

The team then tackled the extraction step, where DNA and RNA are separated from the microbial cells and prepared for sequencing. Commercial extraction kits work well but are expensive, and they require manual handling that introduces operator-to-operator variability. The researchers developed their own inhibitor removal buffer, prepared in-house at a fraction of the cost. They compared this self-made buffer to the standard manual extraction method by running the same samples through both processes. The results were striking: the species abundances measured by the two methods correlated at an R-squared value greater than 0.998, meaning they were essentially identical. The self-prepared buffer performed as well as the commercial alternative while reducing costs.

With both preservation and extraction optimized, the team evaluated the overall workflow for reproducibility. They had different operators run the same samples multiple times, in different batches, to see whether the results were consistent. The inter-operator correlation exceeded R-squared 0.99, indicating that two different people following the protocol would arrive at nearly identical answers. The Shannon diversity index, a standard measure of microbial richness and evenness, remained stable across replicates. These are the metrics that matter in practice: if you send your sample to two different labs, or have two different technicians process it, you should get the same answer.

The workflow now spans the full journey of a sample, from the moment it is collected through the final extraction step. Researchers can choose their preservation buffer based on their specific constraints—fidelity or stability—and can extract nucleic acids using a cost-effective method that performs identically to commercial alternatives. The standardization addresses a real problem in microbiome science: the technical variability that has made it difficult to compare results across studies or to trust that observed differences between patient groups reflect genuine biological differences rather than laboratory artifacts. By reducing this noise, the workflow makes microbiome research more reliable and more reproducible, which means the findings are more likely to hold up when other groups try to replicate them.